Quotes: MENA   Enter Symbol: NewsLetter: Search: advanced

Promethera(R)Biosciences welcomes Frank Hazevoets as chief financial officer  Join our daily free Newsletter

MENAFN Press - 13/05/2014
No. of Ratings : 0
Add to Mixx!

(MENAFN Press) Promethera(R) Biosciences, an innovative orphan drug therapy company that develops stem cell therapies for the treatment of liver diseases, today announces that Frank Hazevoets has joined the company to lead its finance and administration team. Frank joined Promethera Biosciences SA on May 1, 2014 as chief financial officer (CFO). He will be based at the head office in Mont-Saint-Guibert, Belgium.

Frank Hazevoets is a highly experienced senior financial executive with over twenty five years international business experience. He trained at the Catholic University of Leuven (KUL) in Belgium as a commercial engineer and also obtained a masters degree in Artificial Intelligence and Cognitive Science. He has worked in leading positions in corporate finance and investment banking, strategy and business development. During his six years as CFO at Tigenix, he supported the company in its funding and growth strategy and helped them to obtain the first European marketing authorization for cell-based medicinal products in Europe.

"We are delighted that Frank is joining Promethera Biosciences as CFO," said Eric Halioua, chief executive officer. "He is going to play a key role in assisting our future development. Frank Hazevoets has the experience and expertise to strengthen the management team and to prepare the next strategic options at Promethera Biosciences. He will build the finance department to further support the future growth of Promethera(R)."

"I am really looking forward to working with the experienced team at Promethera and to sharing my expertise with them," said Frank Hazevoets, chief financial officer of Promethera Biosciences. "This company has the potential to become one of the leading orphan drug companies in the world. Many patients will benefit from their lead in developing and commercializing innovative cell and orphan therapy products based on propriary technologies."

About Promethera Biosciences:

Promethera Biosciences is a pharmaceutical company that develops innovative therapies for the treatment of orphan liver diseases. It is currently developing two products based on human liver progenitor cells:

Promethera(R) HepaStem is a cell therapy product based on the use of allogeneic stem cells isolated from healthy adult human livers (Heterologous Human Adult Liver Progenitor Cells, HHALPC). These cells can be used to treat a wide variety of liver diseases, from rare inborn metabolic diseases (which can be classified as 'orphan diseases' and mainly affecting children), to acquired deficiencies affecting adults, such as acute-on chronic liver diseases or liver fibrosis. HepaStem is currently tested in phase I/II clinical trial in Europe and Israel for the treatment of two orphan indications.

Promethera(R) H2Screen and H3Screen is a non-therapeutic in vitro product, based on a recently discovered and patented liver progenitor cell type, isolated from healthy adult human livers. This novel biotechnology tool is designed for early preclinical pharmaco-toxicological evaluation of drug candidates and new chemical entities.

Promethera Biosciences is a spin-off of the Universite Catholique de Louvain (UCL), founded in 2009. The company emerged from the lab of Professor Etienne Sokal, a leading expert in pediatric liver disease and cell. Promethera Biosciences is located in Mont-Saint-Guibert (Belgium).

Since its creation in 2009, Promethera Biosciences has raised EUR 34 million in two financial rounds, in capital, grants and loans from the Walloon Region. The main investors are Vesalius Biocapital, Mitsui Global Investment, BI Venture Fund, Shire and SRIW.

Promethera Biosciences has 47 employees led by an experienced management team.

For more information, please visit http://www.promethera.com

About Promethera(R)



  MENA News Headlines
 Nov 29 2015 - Malta improves economic collaboration with OmanMENAFN
(MENAFN) Malta is taking advantage to improve economic cooperation and other fields with Oman, particularly in the area of knowledge sharing.Accordingly, there is huge possible for collaboration, ...

 Nov 29 2015 - Are filmmakers ready to tackle terror? †Can Nov 13 attacks prove gamechanger for popular culture?Arab Times
(MENAFN - Arab Times) Two weeks after suffering the most devastating attack since WWII, France is slowly getting back on its feet. The recent massacre exposed the phenomenon of disenfranchised French ...

 Nov 29 2015 - Kuwait- RSK 'Winter Cup' reaches 3rd week holds 1st kids tourney - Vijayan, Nuansamlee lead Higher bracket qualifiersArab Times
(MENAFN - Arab Times) Tournament 15 "Winter Cup" of RSK Badminton at Kazma Sports Club in Adailiya reaches its last week of eliminations € its 3rd week € and the so-called "twilight zone" as ...

 Nov 29 2015 - KSA imports from German state to hit USD4.2 by 2020MENAFN
(MENAFN) The German State of Baden-Wurttemberg will seek to achieve more than USD4.2 billion exports to Saudi Arabia over the next five years.This striving goal will result in doubling the current ...

 Nov 29 2015 - Kuwait market returns to green zoneArab Times
(MENAFN - Arab Times) Kuwait Stock Exchange (KSE) ended last week in the green zone. The Price Index closed at 5,794.64 points, up by 1.21 percent from the week before closing, the Weighted Index ...

 Nov 29 2015 - Kuwait- No change in policy as OPEC meets in Vienna - 'Silence is the outcome'Arab Times
(MENAFN - Arab Times) OPEC will be meeting in Vienna with "nothing much to be achieved". Every oil minister will be telling himself, "When will the oil prices stop declining?" The low oil prices of ...

 Nov 29 2015 - Gulf Bank celebrates its 55th 'anniversary' - Proud to serve KuwaitArab Times
(MENAFN - Arab Times) Gulf Bank is happy to celebrate its 55th anniversary. On Nov 23, 1960, His Highness Abdullah Salem Al- Sabah, The Amir of Kuwait, signed Amiri Decree No. (44) recognizing Gulf ...

 Nov 29 2015 - Kuwait- Al Sayer announces winners of first raffle draw - 'Biggest promotion ever' on new Toyota modelsArab Times
(MENAFN - Arab Times) Mohamed Naser Al Sayer & Sons, the exclusive dealer for Toyota in Kuwait has announced winners of the first raffle draw from the "biggest promotion ever" on New Toyota models. ...

 Nov 29 2015 - 'More songs"more bombs' - 'We will remain France'Arab Times
(MENAFN - Arab Times) President Francois Hollande vowed Friday to destroy the "army of fanatics" behind the Paris attacks but also said France would respond with more songs, concerts and shows as the ...

 Nov 29 2015 - Suicide bomber kills 7 in Iraq town - Bomb-rigged mass grave of IS victims foundArab Times
(MENAFN - Arab Times) At least seven people were killed in a suicide car bomb attack in a northern Iraqi town that has seen deadly clashes between Kurdish and Shi'ite paramilitary forces, the mayor ...




Click to Apply


Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  

Middle East North Africa - Financial Network

Main News
News By Industry
News By Country

Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices


Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks

Saudi Arabia 

Economic Calendar
Financial Glossary

Financial Calculators

RSS Feeds [XML]

Corporate Monitor


Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters

© 2014 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help